Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients—the COFRASA study
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
AIMS: There is currently no medical therapy that can prevent the progression of aortic valve stenosis (AS). Recent data highlight a possible relationship between bone metabolism and AS progression but prospective data are lacking. METHODS AND RESULTS: Serum levels of calcium, phosphorus, creatinine, 25-OH vitamin D, intact parathyroid hormon (iPTH), C-terminal-telopeptide of type-1-collagen (CTX) and osteocalcin were assessed at baseline in 110 elderly patients (age ≥70 years) with at least mild AS. CTX/osteocalcin ratio was calculated as a marker of bone remodelling balance. AS severity was assessed at baseline and 1-year based on the mean gradient. Two-thirds of patients had low 25-OH vitamin D and 20% had secondary hyperparathyroidism. AS progression was not associated with age, glomerular filtration rate (GFR), calcium and phosphorus levels, calcium-phosphorus product, but significantly with iPTH, CTX/osteocalcin and vitamin D status (all P < 0.01). There was no correlation between iPTH and CTX/osteocalcin (R = 0.04, P = 0.70) and AS progression was associated with CTX/osteocalcin (R = 0.42, P = 0.009), but not with iPTH (R = 0.10, P = 0.55) in patients with normal vitamin D levels, whereas it was associated with iPTH (R = 0.47, P < 0.001) and not with CTX/osteocalcin (R = 0.04, P = 0.73) in those with low vitamin D levels, especially if mild renal insufficiency was present (R = 0.61, P < 0.001). CONCLUSION: In elderly patients with AS, we observed an association between AS progression and vitamin D, iPTH and CTX/osteocalcin ratio and their respective influence varied according to the vitamin D status. In patients with normal vitamin D levels, AS progression was associated with a bone resorptive balance, whereas in patients with low vitamin D levels, AS progression was associated with iPTH and secondary hyperparathyroidism, especially if mild renal insufficiency was present. These findings may have important prognostic and therapeutic implications. Trial registration information: Clinicaltrials.gov identifier number: NCT00338676, funded by AP-HP, the COFRASA study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The clinical factors associated with faster stenosis progression include older age, female sex, severity of the stenosis and degree of aortic valve calcification at diagnosis, smoking, hypertension, obesity, metabolic syndrome, secondary hyperparathyroidism, renal failure elevated circulating levels of Lp(a), and increased activity of Lp-PLA2 (also called lipoprotein–associated phospholipase A2)51”
From Calcific aortic stenosis (2016) · cites this paper as [142]
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Levey, A. S., Eckardt, K.-U., Tsukamoto, Y., Levin, A., Coresh, J., Rossert, J., Zeeuw, D. D. E., Hostetter, T. H., Lameire, N., & Eknoyan, G. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00365.x · Cited by 3,946
Authors/Task Force Members, Vahanian, A., Baumgartner, H., Bax, J., Butchart, E., Dion, R., Filippatos, G., Flachskampf, F., Hall, R., Iung, B., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl428 · Cited by 3,593
Self-citationIung, B. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00201-x · Cited by 3,530
Self-citationEchocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice
Baumgartner, H., Hung, J., Bermejo, J., Chambers, J. B., Evangelista, A., Griffin, B. P., Iung, B., Otto, C. M., Pellikka, P. A., & Quiñones, M. (2009) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2008.11.029 · Cited by 2,126
Self-citationClinical Factors Associated With Calcific Aortic Valve Disease
Stewart, B. F., Siscovick, D., Lind, B. K., Gardin, J. M., Gottdiener, J. S., Smith, V. E., Kitzman, D. W., & Otto, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00563-3 · Cited by 2,029
Levey, A. S., Coresh, J., Greene, T., Marsh, J., Stevens, L. A., Kusek, J. W., Van Lente, F., & for Chronic Kidney Disease Epidemiology Collaboration (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.077180 · Cited by 1,855
Pathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779
Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Otto, C. M., Kuusisto, J., Reichenbach, D. D., Gown, A. M., & O'Brien, K. D. (1994) · Circulation · doi:10.1161/01.cir.90.2.844 · Cited by 1,315
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
Otto, C. M., Lind, B. K., Kitzman, D. W., Gersh, B. J., & Siscovick, D. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907153410302 · Cited by 1,283
Sambrook, P., & Cooper, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68891-0 · Cited by 1,165
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
Cowell, S. J., Newby, D. E., Prescott, R. J., Bloomfield, P., Reid, J., Northridge, D. B., & Boon, N. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043876 · Cited by 1,146
Bone Formation and Inflammation in Cardiac Valves
Mohler, E. R., Gannon, F., Reynolds, C., Zimmerman, R., Keane, M. G., & Kaplan, F. S. (2001) · Circulation · doi:10.1161/01.cir.103.11.1522 · Cited by 1,049
Chan, K. L., Teo, K., Dumesnil, J. G., Ni, A., & Tam, J. (2010) · Circulation · doi:10.1161/circulationaha.109.900027 · Cited by 815
Human Aortic Valve Calcification Is Associated With an Osteoblast Phenotype
Rajamannan, N. M., Subramaniam, M., Rickard, D., Stock, S. R., Donovan, J., Springett, M., Orszulak, T., Fullerton, D. A., Tajik, A. J., Bonow, R. O., et al. (2003) · Circulation · doi:10.1161/01.cir.0000070591.21548.69 · Cited by 725
Vitamin D and disease prevention with special reference to cardiovascular disease
Zittermann, A. (2006) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2006.02.001 · Cited by 447
Osteopontin Is Expressed in Human Aortic Valvular Lesions
O’Brien, K. D., Kuusisto, J., Reichenbach, D. D., Ferguson, M., Giachelli, C., Alpers, C. E., & Otto, C. M. (1995) · Circulation · doi:10.1161/01.cir.92.8.2163 · Cited by 440
AORTIC AND MITRAL VALVE CALCIFICATION IN PATIENTS WITH END-STAGE RENAL DISEASE
MAHER, E. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91370-5 · Cited by 265
Hjortnaes, J., Butcher, J., Figueiredo, J.-L., Riccio, M., Kohler, R. H., Kozloff, K. M., Weissleder, R., & Aikawa, E. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq237 · Cited by 233
Aortic Valve Calcification: Determinants and Progression in the Population
Messika-Zeitoun, D., Bielak, L. F., Peyser, P. A., Sheedy, P. F., Turner, S. T., Nkomo, V. T., Breen, J. F., Maalouf, J., Scott, C., Tajik, A. J., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000255952.47980.c2 · Cited by 207
Self-citationDopamine receptors: applications in clinical cardiology.
Goldberg, L. I., & Rajfer, S. I. (1985) · Circulation · doi:10.1161/01.cir.72.2.245 · Cited by 206
Detection of Osteopontin in Calcified Human Aortic Valves
Mohler, E. R., Adam, L. P., McClelland, P., Graham, L., & Hathaway, D. R. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.3.547 · Cited by 193
The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis
Ortlepp, J. R., Hoffmann, R., Ohme, F., Lauscher, J., Bleckmann, F., & Hanrath, P. (2001) · Heart · doi:10.1136/heart.85.6.635 · Cited by 171
Charles, P., Poser, J. W., Mosekilde, L., & Jensen, F. T. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112234 · Cited by 162
Bisphosphonate Use and Prevalence of Valvular and Vascular Calcification in Women
Elmariah, S., Delaney, J. A. C., O'Brien, K. D., Budoff, M. J., Vogel-Claussen, J., Fuster, V., Kronmal, R. A., & Halperin, J. L. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.050 · Cited by 136
Herrmann, M., & Seibel, M. J. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.03.020 · Cited by 113
García, P., Schwenzer, S., Slotta, J., Scheuer, C., Tami, A., Holstein, J. H., Histing, T., Burkhardt, M., Pohlemann, T., & Menger, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00651.x · Cited by 87
Osteoporosis Treatment and Progression of Aortic Stenosis
Skolnick, A. H., Osranek, M., Formica, P., & Kronzon, I. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.02.051 · Cited by 84
Do Bisphosphonates Slow the Progression of Aortic Stenosis?
Aksoy, O., Çam, A., Goel, S. S., Houghtaling, P. L., Williams, S., Ruiz‐Rodriguez, E., Menon, V., Kapadia, S. R., Tuzcu, E. M., Blackstone, E. H., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.024 · Cited by 76
Parathyroid Hormone and Vitamin D Levels are Independently Associated With Calcific Aortic Stenosis
Linhartová, K., Veselka, J., Štěrbáková, G., Ráček, J., Topolčan, O., & Cerbák, R. (2008) · Circulation Journal · doi:10.1253/circj.72.245 · Cited by 64
Aortic valve calcification: association with bone mineral density and cardiovascular risk factors
Aksoy, Y., Yagmur, C., Tekin, G. O., Yagmur, J., Topal, E., Kekilli, E., Turhan, H., Kosar, F., & Yetkin, E. (2005) · Coronary Artery Disease · doi:10.1097/00019501-200509000-00007 · Cited by 62
Physiological function of the angiotensin AT1a receptor in bone remodeling
Kaneko, K., Ito, M., Fumoto, T., Fukuhara, R., Ishida, J., Fukamizu, A., & Ikeda, K. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.501 · Cited by 61
Calcium Metabolism in Adults With Severe Aortic Valve Stenosis and Preserved Renal Function
Akat, K. M., Kaden, J. J., Schmitz, F., Ewering, S., Anton, A., Klomfaß, S., Hoffmann, R., & Ortlepp, J. R. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.065 · Cited by 45
de Monchy, C. C., Lepage, L., Boutron, I., Leye, M. M. C. B. O., Détaint, D., Hyafil, F., Brochet, É., Iung, B., Vahanian, A. S., & Messika–Zeitoun, D. (2008) · European Journal of Echocardiography · doi:10.1093/ejechocard/jen301 · Cited by 37
Self-citationSverdlov, A. L., Ngo, D. T. M., Chan, W. P. A., Chirkov, Y. Y., Gersh, B. J., McNeil, J. J., & Horowitz, J. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs171 · Cited by 35
[Bone formation and inflammation].
Koinuma, D., & Imamura, T. (2005) · PubMed · Cited by 34
Awan, Z. A., Al-Waili, K., Alshahrani, A., Langsetmo, L., Goltzman, D., & Genest, J. J. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147066 · Cited by 26
Parathyroid hormone gene variant and calcific aortic stenosis.
Schmitz, F., Ewering, S., Zerres, K., Klomfaß, S., Hoffmann, R., & Ortlepp, J. R. (2009) · PubMed · Cited by 20
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.6 · Cited by 982
Self-citationOxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417
“Additionally, other mechanisms may be involved in the older population, including increased dysregulation in mineral metabolism, post-menopausal deficiency in estrogen, and other aging processes (36,37).”
Danielsen, R., Aspelund, T., Harris, T. B., & Gudnason, V. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.053 · Cited by 168
“Vitamin D status, bone remodeling and secondary hyperparathyroidism has also been implicated in AS progression [30].”
BackgroundMedical Treatment of Aortic Stenosis
Marquis-Gravel, G., Redfors, B., Leon, M. B., & Généreux, P. (2016) · Circulation · doi:10.1161/circulationaha.116.023997 · Cited by 162
Metadata
- Authors
- Hekimian, G., Boutten, A., Flamant, M., Duval, X., Dehoux, M., Benessiano, J., Huart, V., Dupré, T., Berjeb, N., Tubach, F., Iung, B., Vahanian, A., & Messika-Zeitoun, D.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-01-17
- Volume
- 34
- Issue
- 25
- Pages
- 1915-1922
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2044635470
- Cited by
- 53
- References
- 43
- Citations by year
- 2025: 6 · 2024: 5 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 6 · 2014: 3 · 2013: 1
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Vitamin D Research Studies
- Keywords
- aortic stenosis, disease progression, bone remodeling, secondary hyperparathyroidism, parathyroid hormone, vitamin D deficiency, 25-hydroxyvitamin D, C-terminal telopeptide of type I collagen, osteocalcin, renal failure, elderly patients, bone metabolism
- MeSH terms
- Aged, Aortic Valve Stenosis, Calcium, Creatinine, Female, Humans, Hyperparathyroidism, Secondary, Male, Parathyroid Hormone, Peptides, Phosphorus, Prospective Studies, Vitamin D, Biomarkers, Osteocalcin, Bone Remodeling, Collagen Type I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.